1 suspended, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 1, Unknown 1 |
Follow Renato Melaragno: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+) Imatinib Mesylate - Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+) | Phase 2 | Unknown | Renato Melaragno | 20 | 2011-02-01 | 2013-03-26 |
| Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) Imatinib Mesylate - Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) | Phase 2 | Suspended | Renato Melaragno | 20 | 2013-03-26 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Brazil (1)